newsfilter
← Latest News
GlobeNewswire·

Trevena to Participate at the H.C. Wainwright Annual Global Investment Conference

CHESTERBROOK, Pa., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced